Description
CJC-1295 With DAC research peptide
CJC-1295 with DAC is a tetrasubstituted GHRH(1-29) analogue with a lysine-linked maleimide group (the Drug Affinity Complex). The DAC binds covalently to albumin, which greatly extends its half-life compared with short-acting GHRH analogues.
Product details
| Compound | CJC-1295 with Drug Affinity Complex (DAC) |
|---|---|
| Class | Long-acting GHRH analogue |
| Format | Lyophilised peptide vial |
| Labelling | Compound name and strength on every container |
What CJC-1295 With DAC research has examined
- Pharmacokinetics: albumin binding and extended half-life of DAC-modified peptides.
- GH axis research: sustained GHRH receptor stimulation and IGF-1 response in early clinical studies.
- Analogue design: comparison with Mod GRF 1-29 (CJC-1295 without DAC).
Research interest does not establish a proven effect in humans.
Regulatory status
CJC-1295 With DAC is not an approved medicine. Growth hormone secretagogues and related peptides are prohibited in sport by WADA, and the material sold here is a research chemical only.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Adamax / Adalank Combo Pack · Healing Research Bundle · Turn Back Time Bundle · All peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.